Feller Stephan M, Lewitzky Marc
Institute of Molecular Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Cell Commun Signal. 2016 Sep 27;14(1):24. doi: 10.1186/s12964-016-0147-9.
Non-protein coding RNAs in different flavors (miRNAs, piRNAs, snoRNAs, lncRNAs, SHOT-RNAs), exosomes, large oncosomes, exoDNA and now tumor-educated platelets (TEPs) have emerged as crucial signal transmitting, transporting and regulating devices of cells in the last two decades. They are also establishing themselves increasingly in the realm of tumor research. We are currently witnessing a mushrooming of candidate entities for diagnostic and prognostic cancer detection and characterization tests that could have a major impact on how this diverse group of diseases is initially spotted and subsequently treated in the near future. But how do the new kids on the block stand up to the more established circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)? Without question, much earlier disease detection would be expected to save numerous lives. With all these new players around, will we finally win a major battle in the never-ending war against cancer?
在过去二十年中,不同类型的非编码RNA(微小RNA、Piwi相互作用RNA、核仁小分子RNA、长链非编码RNA、短链非编码RNA)、外泌体、大肿瘤小体、胞外DNA以及现在的肿瘤驯化血小板已成为细胞中至关重要的信号传递、运输和调节工具。它们在肿瘤研究领域也日益崭露头角。目前,我们正目睹用于癌症诊断和预后检测及特征分析的候选实体如雨后春笋般涌现,这可能会对这类多样疾病在不久的将来如何被初步发现及后续治疗产生重大影响。但是,这些新出现的事物与更成熟的循环肿瘤细胞和循环肿瘤DNA相比如何呢?毫无疑问,更早地检测出疾病有望挽救众多生命。有了所有这些新的参与者,我们最终会在与癌症的持久战中赢得一场重大战役吗?